Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice
Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice
About this item
Full title
Author / Creator
Publisher
BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Inflammation plays a critical role in lung disease development and progression in cystic fibrosis. Azithromycin is used for the treatment of cystic fibrosis lung disease, although its mechanisms of action are poorly understood. We tested the hypothesis that azithromycin modulates lung inflammation in cystic fibrosis mice. Methods We monitored cellu...
Alternative Titles
Full title
Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_9f693f70766540638ea18bd9b19226f8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9f693f70766540638ea18bd9b19226f8
Other Identifiers
ISSN
1465-993X,1465-9921
E-ISSN
1465-993X,1465-9921
DOI
10.1186/1465-9921-7-134
